About Choyang Medics

Medical light
technologies.
Experience
since 2002.

More than two decades of experience in medical equipment for dermatology, from UV phototherapy to medical illumination and laser-based technologies.

Our story
DEVELOPMENT & MANUFACTURINGREPUBLIC OF KOREA
Choyang Medics
Dermatology.
Technology.
Professional practice.
A specialist foundation

Knowledge built
through experience.

Our work combines product development and manufacturing with selected medical-device imports for the Korean market.

Medical light technologies

UV therapy and medical laser equipment have been part of our development and manufacturing activity since the company’s early years.

A dermatology perspective

Our Korean portfolio brings together equipment for dermatology and aesthetic practices, including phototherapy, medical illumination and laser-based devices.

View the Korean portfolio

Development, quality & service

Continued product development, product quality and service are priorities in our company’s approach, supported by an internal research function established in 2015.

Our story

Progress,
over time.

Selected milestones in the development of Choyang Medics, from a business founded in 2002 to its incorporation in 2016 and beyond.

2002Today
  1. 2002

    The beginning

    The business was founded as a sole proprietorship in October, with factory registration. GMP certification and a Korean medical-device manufacturing licence followed in December.

  2. 2003

    An early focus on UV technology

    Manufacturing authorization was obtained for the COSMOLUX N-UVB 6000C ultraviolet therapy device.

  3. 2006–2007

    A broader medical-device portfolio

    The portfolio expanded into medical operating lights and laser equipment. A medical-device import licence was obtained in 2007.

  4. 2011–2012

    Extending the phototherapy range

    Korean manufacturing authorizations or certifications were obtained for UV900N.B, UV700N.B, UV8000N.B and Lem-Light.

  5. 2015

    A dedicated research function

    An internal research department was established in March.

  6. 2016

    A new company chapter

    The business became Choyang Medics Co., Ltd. in January. A dedicated R&D department was established in May.

  7. January 2026

    A quality-management milestone

    ISO 13485 certification was obtained in January 2026.

  8. May 2026

    A milestone for international development

    Completed U.S. FDA 510(k) Clearance for DUV-COMBO (K254234).

January 2026

ISO 13485

Certification obtained
A documented milestone

Quality management.
A continuing focus.

The company’s history records ISO 13485 certification in January 2026, alongside its established medical-device development and manufacturing activities.

Company certification and individual product authorizations are distinct. Refer to each product page for its specific regulatory status and market information.

View international products
A milestone for international development

DUV-COMBO.
U.S. FDA 510(k)-cleared.

In May 2026, Choyang Medics completed U.S. FDA 510(k) clearance for DUV-COMBO, under reference K254234.

This clearance applies to DUV-COMBO. See the product page for its clinical information, regulatory status and market-specific considerations.

View product details
May 2026

U.S. FDA 510(k)

K254234Clearance completed · DUV-COMBO
International development

Rooted in experience.
Open to conversation.

Our international presentation focuses on DUV-COMBO, DUV-HOME and SkinVue. We welcome healthcare professionals and prospective distribution partners to discuss product documentation, their markets and local requirements.

Follow Choyang Medics on LinkedIn (opens in a new tab)